- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT04674371
German Point Prevalence Study on CVC
German Point Prevalence Study on Central Venous Catheter
It has now been 90 years since Werner Forssmann developed the CVC. Nowadays CVCs play an integral role for critically ill patients.
Despite the high number of central venous access devices inserted annually, there are limited data on the incidence of the associated procedural complications, many of which carry substantial clinical risk. This point was highlighted in recently published Association of Anaesthetists of Great Britain and Ireland "Safe vascular access 2016" guidelines and "Clinical guidelines on central venous catheterisation" in 2014 of the Swedish Society of Anaesthesiology and Intensive Care Medicine.
This German point prevalence study should identify the number of central venous catheter insertions and the incidence of various and especially serious mechanical complications across multiple hospital sites within one day.
Secondary aims are to identify the availability of resources and infrastructure to facilitate safe central venous catheter insertion and management of potential complications.
As much hospital sites as possible should participate and identify all adult central venous catheter insertions, with subsequent review of any complications detected.
Additionally, resources while inserting the CVC should be specified such as ultrasound for assessment of ultrasound anatomy and/or ultrasound-guidance. Furthermore, assessment of the CVC tip should be studied whether done during CVC placement with
- ECG-guidance or by
- transthoracic/transesophageal ultrasound with the Microbubble test or more conventional post hoc with
- bedside chest X-ray Any mechanical complication should be documented untill day three post insertion. The background is to identify possible perforations due to initially unfavorable CVC tip positions (angle > 40 ° to wall of the superior vena cava).
Participation in the study is open to all disciplines (anesthesia, intensive care, internal medicine, surgery, etc.) that regularly perform CVCs.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Questions
- How experienced are the CVC operators?
- What are the demographics of the patients included?
- How many emergency patients will be included in the study?
- How is the distribution of the punctured vessels and that of the respective sides?
- How many puncture attempts are necessary to achieve a successful CVC placement and how often do problems with the Seldinger-wire occur?
How often is ultrasound used to place a CVC and if so,
- Only for Screening?
- Puncture under ultrasound view?
- What is the distribution between short and long axis view?
- What catheter types and which caliber in French are being inserted?
Catheter position control:
- by EKG-lead on Pmax or Pmax - x cm (withdroth)
- by means of transthoracic ultrasound and agitated NaCl solution
- by means of transesophageal echocardiography and NaCl solution
- by means of X-ray image
- other or missing position control
- Statement on the position of the CVC tip
- How common are CVC-malpositions and what is their distribution?
- Which complications occur within 72 h? Which measures do you require and how do they affect the respective patient?
Tipo de estudio
Inscripción (Actual)
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Berlin-Mitte, Alemania, 10117
- Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin e.V.
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Niño
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
Descripción
Age
Inclusion criteria:
- Adults
- Young Adults
- Children
- Infants
- Neonates
Exclusion criteria:
- None
Procedures
Inclusion criteria:
- Elective central venous access procedures
- Emergency central venous access procedures
Exclusion criteria:
- None
Providers
Inclusion criteria:
- Anesthesiologists
- Internist
- Neurologist
- Surgeon
- Etc.
Exclusion criteria:
- None
Selection of catheter insertion site
- External jugular
- Internal jugular
- Subclavian
- Femoral
Complications
Inclusion criteria:
- Arterial cannulation/injury/cerebral embolization/hemorrhage
- Catheter or wire shearing or loss
- Lacerations of great vessels
- Exsanguination
- Hemo/pneumothorax; peritoneal hemorrhage
- Pneumothorax
- Tamponade
- Tracheal injury
- Air embolism
- Heart puncture (tamponade)
- Hemothorax
- Stroke
- Mortality
- Number of attempts at central line placement
- Failed insertion attempts
- Successful, nontraumatic procedure
- Wire, needle, catheter issues
Exclusion criteria:
- Infections or other complications not associated with central venous catheterization
- Mechanical injury or trauma not associated with central venous catheterization
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Modelos observacionales: Grupo
- Perspectivas temporales: Futuro
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Patients Demographics
Periodo de tiempo: 17.05.2022
|
All patients with a CVC Insertion on May 17th.
2022 in participating Hospitals independent of sex, age or BMI in kg/m^2 are eligible
|
17.05.2022
|
|
Complications and malpositions
Periodo de tiempo: 17.05.2022-20.05.2022
|
Which complications and malpositions occur within 72 h
|
17.05.2022-20.05.2022
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Percentage of the emergency procedure
Periodo de tiempo: 17.05.2022
|
How many emergency patients will be included in the study
|
17.05.2022
|
|
Distribution of the vessel sites und sides
Periodo de tiempo: 17.05.2022
|
distribution of the punctured vessels (external jugular, internal jugular, subclavian, femoral ) and that of the respective sides |
17.05.2022
|
|
Experience of the operator
Periodo de tiempo: 17.05.2022
|
Resident physician/ Specialist doctor
|
17.05.2022
|
|
Puncture attempts
Periodo de tiempo: 17.05.2022
|
How many puncture attempts are necessary to achieve a successful CVC
|
17.05.2022
|
|
Type and caliber of catheter
Periodo de tiempo: 17.05.2022
|
What catheter types and which caliber in French are being inserted
|
17.05.2022
|
|
Wire problems/issues
Periodo de tiempo: 17.05.2022
|
witch and how often do problems with the Seldinger-wire occur
|
17.05.2022
|
|
Ultrasound assistance
Periodo de tiempo: 17.05.2022
|
Screening / Online guidance / Short or long axis view
|
17.05.2022
|
|
CVC tip position
Periodo de tiempo: 17.05.2022
|
measures to ensure central venous catheter tip position (i.e.
CXR, ECG method and ultrasound)
|
17.05.2022
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Silla de estudio: Wolfram Schummer, MD, PhD, Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin
Publicaciones y enlaces útiles
Publicaciones Generales
- Schmidt GA, Blaivas M, Conrad SA, Corradi F, Koenig S, Lamperti M, Saugel B, Schummer W, Slama M. Ultrasound-guided vascular access in critical illness. Intensive Care Med. 2019 Apr;45(4):434-446. doi: 10.1007/s00134-019-05564-7. Epub 2019 Feb 18. Review.
- McGee DC, Gould MK. Preventing complications of central venous catheterization. N Engl J Med. 2003 Mar 20;348(12):1123-33. doi: 10.1056/NEJMra011883. No abstract available.
- Schummer W, Sakka SG, Hüttemann E, Reinhart K, Schummer C. [Ultrasound guidance for placement control of central venous catheterization. Survey of 802 anesthesia departments for 2007 in Germany]. Anaesthesist. 2009 Jul;58(7):677-85. doi: 10.1007/s00101-009-1569-1. German.
- Frykholm P, Pikwer A, Hammarskjold F, Larsson AT, Lindgren S, Lindwall R, Taxbro K, Oberg F, Acosta S, Akeson J. Clinical guidelines on central venous catheterisation. Swedish Society of Anaesthesiology and Intensive Care Medicine. Acta Anaesthesiol Scand. 2014 May;58(5):508-24. doi: 10.1111/aas.12295. Epub 2014 Mar 5.
- Coe AJ. AAGBI Safe vascular access guidelines I. Anaesthesia. 2016 Aug;71(8):985. doi: 10.1111/anae.13553.
- Bierman S. AAGBI safe vascular access guidelines II. Anaesthesia. 2016 Aug;71(8):985-6. doi: 10.1111/anae.13554.
- Lathey RK, Jackson RE, Bodenham A, Harper D, Patle V; Anaesthetic Audit and Research Matrix of Yorkshire (AARMY). A multicentre snapshot study of the incidence of serious procedural complications secondary to central venous catheterisation. Anaesthesia. 2017 Mar;72(3):328-334. doi: 10.1111/anae.13774. Epub 2016 Dec 16.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
- Catéter venoso central
- vía venosa central
- Catheterization, Central Venous / access
- Catheterization, Central Venous / methods
- Catheterization, Central Venous / instrumentation
- Catheterization, Central Venous / adverse effects
- Placement of larger catheters
- Insertion of CVCs
- Complication of CVCs
- CVC misplacement
- Ultrasonography, Interventional / adverse effects
- Ultrasonography, Interventional / instrumentation
- Ultrasonography, Interventional / methods
- Electroctrocardiography, Radiography, Echocardiographie/ TEE
- Vascular Access Devices / standards
- Vascular Access Devices / trends
- Critical Illness / therapy
- Humanos
- Adults, Adolescents
Otros números de identificación del estudio
- DRKS00016855
- U1111-1229-1554 (Identificador de registro: World Health Organization [WHO] Registry Network)
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
producto fabricado y exportado desde los EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .